📋 Tender Overview
Holographic Optical Tweezing Bioprinting (Hotb): Towards Precise Manipulation Of Cells For Artificial Multi-Scaled Vascularized Tissues/Organ Printing.
Funded Under
European Research Council (Erc)
Total Cost
€ 1 965 525,00
Eu Contribution
€ 1 965 525,00
Coordinated By
Universidade Da Coruna
Spain
Objective
Because current limitations in 3D bioprinting for tissue engineering stem from the fact that the multi-scaled vasculature associated to the human microtissues and organs cannot be replicated. The overarching aim of the HOT-BIOPRINTING project is to deliver a methodology enabling the manufacturing of a new generation of tissue-like structures with properties mimicking more closely the complexity of biological tissues and organs. The innovation of HOT-BIOPRINTING lies on the development of a disruptive technology named Holographic optical tweezing bioprinting (HOTB) for single and automatized multiple cell 3D bioprinting. The non-contact nature of light will eliminate the fails on bioprinting associated to instrumentation, which along with the HOTB capabilities for manipulating single cells for printing will drive a new paradigm shift: resolution will be dictated by the cell size instead of by the mechanical component of the instrumentation . This new technological advancement for resolution enhancement while maintaining bioprinting speed using holographic automatization can open new opportunities to the tissue engineering and regenerative medicine community.
I propose the following general objectives that go beyond the state of the art in bioprinting human mimetic tissue:
1) Generate the knowledge and develop a Holographic Optical tweezer bioprinter (HOTB) for high-definition single/multiple cell bioprinting.
2) Demonstration and automatization for 3D multicellular printing for large area tissue generation.
3) Overcome the challenges associated with existing biofabrication techniques (limited multi-scaled vascularization and oversimplified structures).
4) Demonstrating lymph-node bioprinting with integrated vasculature.
This represents a big challenge, if achieved, will revolutionize the bioprint technology by increasing the tissue complexity and by responding to the demand of biofabricating multi-scale vascularized complex tissues and organs.
